AVID RADIOPHARMACEUTICALS
Avid develops molecular imaging agents to aid medical management of chronic human diseases. They are located in Philadelphia, PA. Their mission is to develop new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies.
AVID RADIOPHARMACEUTICALS
Social Links:
Industry:
Biotechnology Diabetes Pharmaceutical
Founded:
2005-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.avidrp.com
Total Employee:
51+
Status:
Active
Contact:
(215)298-0700
Email Addresses:
[email protected]
Total Funding:
69.9 M USD
Technology used in webpage:
Domain Not Resolving SPF Google Maps Amazon Nginx Microsoft Exchange Online Microsoft Azure DNS Amazon SSL DMARC Amazon Ohio Region
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals develops oral therapies to treat cancers and other critical diseases.
Function Health
100 Healthy Years • Your new routine of 120+ advanced lab tests explained by the world's top doctors
Impact Nano
Impact Nano is a development partner materials supplier with expertise in ligand, organometallic, silicon, and fluorine chemistry.
INanoBio
INanoBiodevelop high-accuracy early-stage disease diagnostics using transformative nano-biotechnology platforms and machine learning.
Turing Medical
Turing Medical creates medical imaging software with the goal of revolutionizing neuroimaging methods.
PaxMedica
PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.
Voltron Therapeutics
Voltron Therapeutics develops precision-guided, self-assembling vaccines for cancer and infectious diseases.
Waypoint Bio
Waypoint Bio is a biotechnology company developing therapeutic treatments for rare genetic diseases
Current Advisors List
Current Employees Featured
Founder
Investors List
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series D - Avid Radiopharmaceuticals
Pfizer Venture Investments
Pfizer Venture Investments investment in Series D - Avid Radiopharmaceuticals
BioAdvance
BioAdvance investment in Series D - Avid Radiopharmaceuticals
AllianceBernstein
AllianceBernstein investment in Series D - Avid Radiopharmaceuticals
RK Ventures Group
RK Ventures Group investment in Series D - Avid Radiopharmaceuticals
Safeguard Scientifics
Safeguard Scientifics investment in Series D - Avid Radiopharmaceuticals
Alta Partners
Alta Partners investment in Series D - Avid Radiopharmaceuticals
Lilly Ventures
Lilly Ventures investment in Series D - Avid Radiopharmaceuticals
Lilly Ventures
Lilly Ventures investment in Series C - Avid Radiopharmaceuticals
RK Ventures Group
RK Ventures Group investment in Series C - Avid Radiopharmaceuticals
Official Site Inspections
http://www.avidrp.com
- Host name: crs.ultradns.net
- IP address: 204.74.99.100
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Avid Radiopharmaceuticals"
Avid Radiopharmaceuticals - Crunchbase Company Profile
Sub-Organization of . Eli Lilly . Founded Date 2005; Founders Daniel M. Skovronsky; Operating Status Active; Last Funding Type Series D; Legal Name Avid Radiopharmaceuticals, Inc. …See details»
Avid Radiopharmaceuticals, Inc.
Nov 1, 2024 www.avidrp.com. Subsidiary Company | 2005 | Pennsylvania, United States | 50-100 | www.avidrp.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Avid Radiopharmaceuticals - Wikipedia
Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, and based at the University City Science Center research campus in Philadelphia, Pennsylvania. The company has developed a radioactive tracer called florbetapir ( F). Florbetapir can be used to detect beta amyloid plaques in patients with memory problems using positron emission tomography (PET) scans, making the company the first to bring to market an FDA-approved method that ca…See details»
Avid RadioPharmaceuticals Company Profile | Management and
Avid RadioPharmaceuticals Profile and History. Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, and based at the University City Science Center …See details»
Avid Radiopharmaceuticals - LinkedIn
Avid Radiopharmaceuticals | 6,102 followers on LinkedIn. Improving patient lives by developing molecular imaging agents to accelerate clinical development | At Avid, a wholly owned …See details»
Avid Radiopharmaceuticals - Craft
Avid Radiopharmaceuticals is a company developing molecular imaging agents for chronic human diseases. It aims to combine medical imaging and CNS development experience for pre …See details»
AVID RADIOPHARMACEUTICALS, INC. - VentureRadar
Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, and based at the University City Science Center research campus... ... Find out ...See details»
Avid Radiopharmaceuticals - PitchBook
Avid Radiopharmaceuticals General Information Description. Developer of molecular imaging compounds intended for detecting and monitoring chronic human diseases. The company …See details»
Avid RadioPharmaceuticals - Overview, News & Similar ... - ZoomInfo
Mar 22, 2023 Radiopharmaceuticals Market to Hit USD 10.26 Billion by 2030 due to Increasing Prevalence of Cancer and Cardiovascular Diseases Worldwide As per SNS Insider analysis, …See details»
Avid - Company Profile - Tracxn
Nov 17, 2024 Avid - Developer of molecular imaging agents for chronic disease diagnosis. Acquired by Lilly. Raised a total funding of $69.9M over 4 rounds from 9 investors. Founded by …See details»
Avid | Subsidiaries | Eli Lilly and Company
Our Mission. At Avid, a wholly-owned subsidiary of Eli Lilly and Company, our mission is to discover, develop, and deliver diagnostic solutions that improve global health by accelerating …See details»
Avid Radiopharmaceuticals - edgein.io
At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic …See details»
Avid Radiopharmaceuticals - Wikiwand
Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, and based at the University City Science Center research campus in Philadelphia, …See details»
Lilly to Acquire Avid Radiopharmaceuticals
Nov 8, 2010 More information about Avid is available at www.avidrp.com. About Eli Lilly and Company Lilly , a leading innovation-driven corporation, is developing a growing portfolio of …See details»
Avid Radiopharmaceuticals, Inc. Closes $34.5 Million Series
May 21, 2009 PHILADELPHIA--(BUSINESS WIRE)--Avid Radiopharmaceuticals, Inc., a leader in the development of molecular imaging products, today announced it completed the first …See details»
Lilly to Acquire Avid Radiopharmaceuticals - PR Newswire
Nov 8, 2010 More information about Avid is available at www.avidrp.com. About Eli Lilly and Company. Lilly, a leading innovation-driven corporation, ...See details»
Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing
May 21, 2009 Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing Proceeds Are Sufficient to Fund Phase III Development, NDA Filing and Launch of 18F-AV-45, a First-in …See details»
Avid Radiopharmaceuticals, Inc. Strengthens Its Drug And
PHILADELPHIA, June 1 /PRNewswire/ -- Avid Radiopharmaceuticals, Inc. (Avid RP), a product-focused molecular imaging company, today announced the addition of three senior executives …See details»
Press Releases - Cardinal Health News & Media
Mar 25, 2010 Cardinal Health to acquire Specialty Networks and its PPS Analytics platform, a technology enabled multi-specialty group purchasing and practice enhancement organization …See details»
Lilly to Acquire Avid Radiopharmaceuticals | Fierce Pharma
Nov 8, 2010 Under the terms of the agreement, Lilly will acquire all outstanding shares of Avid for an upfront payment of $300 million, subject to adjustment based on existing cash on hand …See details»